What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2020-07-23 compared with 2020-05-14 · 28 added, 21 removed, 25 unchanged (66% of the section changed)

OTHER INFORMATION.

of Designations (Series D Convertible Preferred Stock) (filed as Exhibit 10.2 to the Company’s Current Report on Form

8-K filed on January 30, 2020 and incorporated herein by reference).

of Designations (Series E Convertible Preferred Stock) (filed as Exhibit 10.7 to the Company’s Current Report on Form

8-K filed January 30, 2020 and incorporated herein by reference).

of Change Pursuant to NRS 78.209.

(filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed February 28,

2020 and incorporated herein by reference).

Certificate of Amendment to Amended and Restated Articles of Incorporation, as amended, of Sigma Labs, Inc.

(filed as Exhibit 3.1 to the Company's Current Report on Form 8-K filed on April 2, 2020 and incorporated herein by reference).

Amendment Number Two to Amended and Restated Bylaws of Sigma Labs, Inc (filed as Exhibit 3.1 to the Company's Current Report on Form 8-K filed on March 25, 2020 and incorporated herein by reference).

of Institutional Common Warrant (filed as Exhibit 10.4 to the Company’s Current Report on Form 8-K, filed January 30,

2020, and incorporated herein by reference).

of Preferred Warrant (filed as Exhibit 10.5 to the Company’s Current Report on Form 8-K, filed January 30, 2020, and

of Amendment to Amended and Restated Articles of Incorporation, as amended, of Sigma Labs, Inc.

(filed as Exhibit 3.1 to the

Company’s Current Report on Form 8-K filed on April 2, 2020 and incorporated herein by reference).

of Amendment to Amended and Restated Articles of Incorporation, as amended,

of Sigma Labs, Inc.

(filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed June 19, 2020 and

incorporated herein by reference).

of Class A Warrant (filed as Exhibit 10.8 to the Company’s Current Report on Form 8-K, filed January 30, 2020, and incorporated

herein by reference).

Purchase Agreement (Institutional Investors) (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed

January 27, 2020, and incorporated herein by reference).

Rights Agreement (filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed January 27, 2020, and incorporated

of Pre-Funded Warrant (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed April 3, 2020, and incorporated

herein by reference).

Purchase Agreement (Other Investors) (filed as Exhibit 10.6 to the Company’s Current Report on Form 8-K, filed January

of Common Stock Purchase Warrants (filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed April 3,

2020, and incorporated herein by reference).

Placement Agency Agreement (filed as Exhibit 10.9 to the Company’s Current Report on Form 8-K, filed January 30, 2020, and incorporated herein by reference).

of Limited Waiver (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed February 4, 2020, and incorporated

of Placement Warrant (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed April 7, 2020, and incorporated

herein by reference).

Purchase Agreement, dated as of April 2, 2020, between the Company and Purchasers (filed as Exhibit 10.1 to the Company’s

Current Report on Form 8-K filed April 3, 2020, and incorporated herein by reference).

Agency Agreement dated as of April 2, 2020 between the Company and Dawson James (filed as Exhibit 10.4 to the Company’s

Current Report on Form 8-K filed April 3, 2020, and incorporated herein by reference).

Agreement, dated as of May 1, 2020, between Sigma Labs, Inc.

and John Rice (filed as Exhibit 10.1 to the Company’s Current

Report on Form 8-K filed May 4, 2020, and incorporated herein by reference).

2013 Equity Incentive Plan, as Amended (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed

June 19, 2020 and incorporated herein by reference).*

2020 Stock Appreciation Rights Plan (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed

June 29, 2020 and incorporated herein by reference).*

of Stock Appreciation Rights Agreement (Employees;

2020 Stock Appreciation Rights Plan) (filed as Exhibit 10.2 to the Company’s

Current Report on Form 8-K filed June 29, 2020 and incorporated herein by reference).*

of Stock Appreciation Rights Agreement (Non-employee Directors;

2020 Stock Appreciation Rights Plan) (filed as Exhibit 10.3

to the Company’s Current Report on Form 8-K filed June 29, 2020 and incorporated herein by reference).

13a-14(a) Certification of Principal Executive Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**

10 unchanged sentences

Presentation Linkbase Document.

Indicates a management contract or compensatory plan or arrangement.

Filed herewith.

3 unchanged sentences

by the undersigned, thereunto duly authorized.

Mark K Ruport

and Chief Executive Officer (Principal Executive Officer)

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information